Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CSNK1A1
REST API REST API
Homo sapiens
CSNK1A1 is differentially expressed in 305 experiments: 164 organism parts: bone marrow, liver, ... (162 more);, 231 disease states: normal, prostate carcinoma, ... (229 more);, 96 cell types 478 cell lines 40 compound treatments and 85 other conditions.
Synonyms CK1
Orthologs KC1A_CHICK (Gallus gallus)   Csnk1a1 (Mus musculus)   csnk1a1 (Danio rerio)   csnk1a1 (Danio rerio)   Csnk1a1 (Rattus norvegicus)   CkIalpha (Drosophila melanogaster)   E1BEW4_BOVIN (Bos taurus)   F6VHY6_CIOIN (Ciona intestinalis)   F6W3R8_CIOIN (Ciona intestinalis)   csnk1a1 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term cytosol, cell division, protein binding, nuclear speck, cytoskeleton, mRNA cleavage and polyadenylation specificity factor complex, cytoplasm, protein tyrosine kinase activity, condensed chromosome kinetochore, cell morphogenesis, ATP binding, cell cycle, Wnt receptor signaling pathway, centrosome, transferase activity, transferring phosphorus-containing groups, cell surface receptor linked signaling pathway, nucleus, mitosis, nucleotide binding, protein serine/threonine kinase activity, chromosome, signal transduction, protein kinase activity, protein phosphorylation
InterPro Term Prot_kinase_cat_dom, Ser/Thr_kinase_dom, Tyr_kinase_cat_dom, Ser-Thr/Tyr_kinase, Se/Thr_kinase-like_dom
UniProt Accession P48729, Q71TU5, D6REM4, D6RGE5, B4E1D9, B4DFH4, B4DER9, E5RG27, E7ETM0
Search EB-eye ENSG00000113712
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-GEOD-22541, E-GEOD-6573, E-GEOD-3526, E-MTAB-62, ... (28 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (40 experiments)

Factor Value U/D Experiments
SW480
3
E-MEXP-1014, E-MTAB-37, E-GEOD-18005
MCF-7
1
3
E-GEOD-19639, E-GEOD-5823, E-GEOD-20081, E-GEOD-3529
UACC812
2
E-MTAB-37, E-MTAB-62
BT474
2
E-MTAB-37, E-MTAB-62
KG1
2
E-MTAB-37, E-GEOD-24147
MDA468
2
E-MTAB-62, E-MEXP-440
472 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-19397, E-GEOD-3920, E-GEOD-4219, ... (45 experiments)

Factor Value U/D Experiments
fibroblast
3
E-GEOD-3204, E-GEOD-26672, E-GEOD-3920
CD8+ T cell
2
E-AFMX-5, E-GEOD-6740
mononuclear
2
E-GEOD-13987, E-GEOD-26672
squamous cell
1
E-GEOD-19397
alveolar space neutrophil
1
E-GEOD-2322
tumor cell
1
E-MEXP-1327
90 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-1577, E-TABM-15, E-GEOD-12254, ... (64 experiments)

Factor Value U/D Experiments
prostate carcinoma
1
5
E-GEOD-96, E-MEXP-2034, E-MTAB-62, E-MTAB-37, E-GEOD-7307, ... (6 experiments)
lung adenocarcinoma
3
E-MTAB-37, E-MEXP-231, E-MTAB-62
glioblastoma
1
3
E-GEOD-4290, E-MTAB-37, E-MTAB-62, E-MEXP-567
acute lymphoblastic leukemia
2
E-MTAB-37, E-MTAB-62
cervical carcinoma
2
E-MTAB-62, E-MTAB-37
colon carcinoma
2
E-MTAB-62, E-MTAB-37
225 more value(s).


Compound treatment

studied in E-GEOD-1417, E-TABM-782, E-GEOD-5824, E-TABM-868, E-MEXP-1958, ... (27 experiments)

Factor Value U/D Experiments
none
3
6
E-GEOD-5824, E-MEXP-1958, E-TABM-782, E-GEOD-5099, E-TABM-868, ... (9 experiments)
glutamine
2
E-MEXP-1335, E-MEXP-941
BCR/ABL1
1
E-GEOD-15811
sapphyrin PCI-2054
1
E-GEOD-6400
TNF
1
E-GEOD-15205
gamma-secretase inhibitor DAPT
1
E-GEOD-6495
34 more value(s).


A rna yield

studied in E-TABM-325

Factor Value U/D Experiments
74.51
1
1
E-TABM-325


Agent
studied in E-GEOD-19519

Biosource provider
studied in E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-TABM-125, ... (10 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (10 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-2171, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-19743, E-GEOD-1638, E-GEOD-20033, E-MEXP-2359, E-GEOD-6236, ... (8 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-89, E-GEOD-19743, E-GEOD-3325, E-GEOD-22541, E-GEOD-22148, ... (10 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-4086

Er
studied in E-GEOD-20194, E-GEOD-16716

Er ihc
studied in E-GEOD-21653

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (8 experiments)

Genotype
studied in E-GEOD-1045, E-GEOD-17476, E-GEOD-22593, E-GEOD-18005, E-TABM-868, ... (14 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-7011, E-MEXP-2657, E-TABM-127, E-GEOD-20540, E-GEOD-20504, ... (11 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-302, E-GEOD-21653, E-TABM-276, E-GEOD-20194, ... (6 experiments)

Individual
studied in E-TABM-325, E-MTAB-197, E-MEXP-1956, E-MEXP-2069, E-GEOD-16363, ... (32 experiments)

Infection
studied in E-GEOD-12254, E-GEOD-9723, E-MEXP-561, E-GEOD-17400

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-19703, E-GEOD-1309, E-GEOD-22152, E-GEOD-21750, E-GEOD-1657, ... (9 experiments)

Population
studied in E-MTAB-197, E-GEOD-4922, E-GEOD-4342

Pr ihc
studied in E-GEOD-21653

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-MEXP-2115, E-MEXP-1509, E-MEXP-101, E-MEXP-548, E-MEXP-1857, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-17400, E-GEOD-18995

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-1643, E-GEOD-22541, E-GEOD-7307

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-4883, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-13818, E-GEOD-12198 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-22541, E-GEOD-1561, E-GEOD-4922 ... (5 experiments)

Tumor size
studied in E-GEOD-8167

Vehicle
studied in E-GEOD-5258

Processing time: 0.377 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM